Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xmark JV Investment Partners is a healthcare-focused investment vehicle managed by Xmark Opportunity Partners. The firm specializes in providing strategic capital to life science, biotechnology, and pharmaceutical companies, often through structured investments or joint ventures. It has historically been involved in financing rounds for clinical-stage biopharmaceutical companies, such as Keryx Biopharmaceuticals and Aeterna Zentaris. The entity functions as a strategic investor rather than a drug developer, focusing on identifying and supporting undervalued assets in the healthcare sector. It is headquartered in New York and led by experienced healthcare investment professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xmark JV Investment Partners.